Case Reports

Pelvic pleomorphic rhabdomyosarcoma presenting as oliguria in a 61-year-old woman


 

Rhabdomyosarcomas (RMSs) are malignant soft-tissue tumors arising from skeletal muscle progenitor cells.1 They are most commonly diagnosed in children and adolescents and are rare in adults. These tumors arise from a variety of anatomical sites, including the head and neck, urogenital tract, and extremities. Classification of RMSs depends on histopathologic and immunohistochemical features. Embryonal and alveolar subtypes are more common in children and adolescents, whereas the pleomorphic subtype is seen almost exclusively in adults. Adult RMS is associated with poor outcomes and high recurrence rate.2,3 Because of the low incidence of adult RMS, most published reports of RMS in adults are either case series or retrospective analyses, and most treatment protocols are extrapolated from clinical trials performed in children. The present report describes a 61-year-old woman with RMS whose presentation included atypical symptoms

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Pazopanib shows promise as pediatric sarcoma therapy
MDedge Hematology and Oncology
Liquid biopsies may solve GIST biopsy problem
MDedge Hematology and Oncology
Role for GIST genotyping stirs controversy
MDedge Hematology and Oncology
Europe’s latest sarcoma guidelines increase emphasis on genetic profiling
MDedge Hematology and Oncology
Some consider denosumab standard treatment for unresectable giant cell tumor of bone
MDedge Hematology and Oncology
Doxorubicin, ifosfamide combination touted for advanced sarcomas
MDedge Hematology and Oncology
The push for smaller, smarter cancer trials
MDedge Hematology and Oncology
Pazopanib helps significant minority of sarcoma patients
MDedge Hematology and Oncology
Launch of rare-cancer trial spurs many more
MDedge Hematology and Oncology
Long-term follow-up shows 22% survival rate for advanced GIST
MDedge Hematology and Oncology